C. Montoliu et al., ACTIVATION OF THE METABOTROPIC GLUTAMATE-RECEPTOR MGLUR5 PREVENTS GLUTAMATE TOXICITY IN PRIMARY CULTURES OF CEREBELLAR NEURONS, The Journal of pharmacology and experimental therapeutics, 281(2), 1997, pp. 643-647
1-Aminocyclopentane-trans-1,3-dicarboxylic acid, an agonist of the met
abotropic glutamate receptors 1, 2, 3 and 5, prevents neurotoxicity of
glutamate and of N-methyl-D-aspartate in primary cultures of cerebell
ar neurons. The aim of this work was to assess which of the metabotrop
ic glutamate receptors (mGluRs) is responsible for the protective effe
ct. We tested the protective effects of selective agonists for each ty
pe of receptor. It is shown that glutamate and N-methyl-D-aspartate ne
urotoxicity are prevented by the following compounds: 1-aminocyclo-pen
tane-trans-1,3-dicarboxylic acid, agonist of mGluR1, 2, 3 and 5; 3,5-d
ihydroxyphenylglycine, agonist of mGluR1 and 5; S-4-carboxy-3-hydroxyp
henylglycine, agonist of mGluR5 and antagonist of mGluR1; trans-azetid
ine-2,4-dicarboxylic acid, agonist of mGluR5, Glutamate neurotoxicity
is not prevented by (2S,1'S,2'S)-2-(2'-carboxycyclopropyl)glycine, an
agonist of mGluR2 and mGluR3. Moreover, the protective effect of 1-ami
nocyclo-pentane-trans-1,3-dicarboxylic acid is prevented by alpha-meth
yl-4-carboxyphenylglycine, an antagonist of mGluR1 and 5, but not by a
lpha-methyl-4-tetrazoylphenylglycine, an antagonist of mGluR2 and 3. A
protective effect of activation of mGluR1 can not be ruled out becaus
e of the limitations imposed by the lack of specificity of the agonist
s and antagonists currently available. The results shown clearly indic
ate that activation of mGluR5 prevents glutamate and N-methyl-D-aspart
ate neurotoxicity in primary cultures of cerebellar neurons.